Filing Details

Accession Number:
0001600620-24-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-07 16:43:47
Reporting Period:
2024-03-06
Accepted Time:
2024-03-07 16:43:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH Pharmaceutical Preparations (2834) 981231763
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1636642 Maxwell Matthew Donley #140, 14315-118 Avenue
Edmonton A0 T5L 4S6
Evp, Ops & Strategy No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-06 40,665 $5.51 584,072 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 2, 2022 and March 2, 2023 grants.
  2. The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.475 to $5.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.